Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa
about
sameAs
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in miceMET: a critical player in tumorigenesis and therapeutic targetRole of plasma kallikrein in diabetes and metabolismAn allosteric switch for pro-HGF/Met signaling using zymogen activator peptidesHepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1Gold(III) compound is a novel chemocytotoxic agent for hepatocellular carcinomaHepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancersChemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathwaysc-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptaseThe involvement of proteoglycans in the human plasma prekallikrein interaction with the cell surface.Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonistKinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikrein.Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.Hepatocyte growth factor activator (HGFA): a serine protease that links tissue injury to activation of hepatocyte growth factor.Mechanisms of hepatocyte growth factor activation in cancer tissues.TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer.Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma.Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent.Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.Expression of the plasma prekallikrein gene: utilization of multiple transcription start sites and alternative promoter regions.Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling.Allosteric peptide activators of pro-hepatocyte growth factor stimulate Met signaling.Alternative proteolytic processing of hepatocyte growth factor during wound repairPlasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.A novel mechanism in maggot debridement therapy: protease in excretion/secretion promotes hepatocyte growth factor production.Visualisation of transforming growth factor-beta 1, tissue kallikrein, and kinin and transforming growth factor-beta receptors on human clear-cell renal carcinoma cells.Prochemerin cleavage by factor XIa links coagulation and inflammation.
P2860
Q24561588-25486C2D-6E58-45A1-A0C7-B4D5C4B6B6F7Q27008925-7FCAEBD5-E957-41F4-ADD8-4C2FB8E71673Q27016431-08DD3A47-4C6C-437D-9B8F-48ED4286F265Q27690294-CB8C3816-F250-4831-AF43-4072A7E5397BQ27863809-5FE62E39-9C3F-45BF-B70B-350A1D4CC046Q28180175-41BAB620-AF54-417F-9A0F-12A59720F751Q28580848-155DD7B5-98AB-4B5C-8F91-7467156D1049Q31161402-A9587198-7BE2-42FD-A592-0CCC8FCD6338Q34003880-8217A87E-A464-4DD2-BF09-D6F6EAD7F859Q34883707-E7CB8B38-7936-4DD4-98F1-B6863AF974EDQ35118601-B3F71A04-A7FA-415C-A97A-6F539818EBC9Q35689753-575A1F01-291C-4319-A397-1C1A253D8E87Q37375631-291A95C4-776F-4144-B198-D264A30963E6Q37460349-4A8EE3B9-B7D2-447F-95A3-C9A218B74221Q37733689-57070DA7-20D6-4896-BFD2-CD5DD1C5FA33Q38255480-8D8C5115-067B-43C5-89ED-27071284B4ECQ38339809-C197B61F-45F8-4078-A30F-69643874474BQ38425301-5DADAC27-7598-4EB5-A006-3EBF3BC42719Q38429421-0AE06E1A-88C9-4543-B8F5-B267A57F3BACQ38488236-22D872FD-F811-47EB-A5F0-251AC0CC1D04Q39850267-882D082A-F7CB-4668-BECA-61AEE72020F9Q40020532-65F00323-8301-459D-B72C-1A87F5ADC9EEQ40432823-277C99B6-5FCC-4D73-BA53-B3750CA02571Q40541604-54BBB6E0-BCFB-41C7-BA5C-265F127C8D80Q41131252-E4550CFA-777A-4AA1-B261-FB4A47731F41Q42151554-6C74D31F-720F-4E5D-B8D8-C45169BDECEAQ42799009-EEAB6939-CBA6-4E14-852D-F1EAE43E5EF0Q42806275-B6481D7C-EE60-44DB-A193-0EC36F871A72Q46404967-AFB296F6-C387-4BDC-B10A-F672467C3343Q47702346-130D7DCD-C76F-4573-8827-4BE90313AA19
P2860
Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Unusual proteolytic activation ...... ein and coagulation factor XIa
@ast
Unusual proteolytic activation ...... ein and coagulation factor XIa
@en
Unusual proteolytic activation ...... ein and coagulation factor XIa
@nl
type
label
Unusual proteolytic activation ...... ein and coagulation factor XIa
@ast
Unusual proteolytic activation ...... ein and coagulation factor XIa
@en
Unusual proteolytic activation ...... ein and coagulation factor XIa
@nl
prefLabel
Unusual proteolytic activation ...... ein and coagulation factor XIa
@ast
Unusual proteolytic activation ...... ein and coagulation factor XIa
@en
Unusual proteolytic activation ...... ein and coagulation factor XIa
@nl
P2093
P356
P1476
Unusual proteolytic activation ...... ein and coagulation factor XIa
@en
P2093
Daniel Kirchhofer
Dineli Wickramasinghe
Nerissa Mendoza
Paul Moran
P304
P356
10.1074/JBC.M209778200
P407
P577
2002-12-06T00:00:00Z